Zacks Research Downgrades Takeda Pharmaceutical (NYSE:TAK) to Strong Sell
Takeda Pharmaceutical (NYSE:TAK – Get Free Report) was downgraded by Zacks Research from a “hold” rating to a “strong sell” rating in a research report issued to clients and investors on Monday,Zacks.com reports. A number of other brokerages have also weighed in on TAK. Sanford C. Bernstein upgraded Takeda Pharmaceutical from a “market perform” rating […]
1 Jul 08:26 · The Cerbat Gem